‹ Back
Ara-290, Cibinetide
How it works
Ara-290 switches on the injury-only repair receptor to regrow small nerves, calm inflammation and protect vessels and islets; open each pathway below.
Sources
Read the original sources
- Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor (Summary · checked 2026-10-13)
- Erythropoietin receptor family, IUPHAR/BPS (Indexed receptor summary; live page requires access · checked 2026-10-13)
- Nonerythropoietic tissue-protective peptides derived from erythropoietin (2008 · Abstract and indexed figures; originating model experiments · checked 2026-10-13)
- ARA 290 improves symptoms in patients with sarcoidosis-associated small nerve fiber loss and increases corneal nerve fiber density (Abstract · checked 2026-10-13)
- Cibinetide: sarcoidosis small nerve fibre trial (Culver and colleagues · 2017 · Published abstract · checked 2026-10-08)
- ARA 290, a nonerythropoietic peptide engineered from erythropoietin, improves metabolic control and neuropathic symptoms in patients with type 2 diabetes (Abstract · checked 2026-10-13)
- The vasoreparative potential of endothelial colony-forming cells in the ischemic retina is enhanced by cibinetide, a non-hematopoietic erythropoietin mimetic. (O'Leary · 2019 · Abstract; full methods not assumed · checked 2026-10-13)
- Improvement of Islet Allograft Function Using Cibinetide, an Innate Repair Receptor Ligand. (Yao · 2020 · Abstract; full methods not assumed · checked 2026-10-13)